Abstract
We aimed to assess the efficacy of a pneumococcal conjugate vaccine against acute otitis media (AOM) positive by pneumolysin-PCR (Ply-PCR). 1662 infants vaccinated with PncCRM or control vaccine using random allocation were followed for AOM up to 24 months of age. When AOM was diagnosed a middle ear fluid sample was obtained for etiological assays. During the per protocol follow-up period the PncCRM vaccine efficacy was 19% against Ply-PCR-positive AOM but only 3% when culture-positive cases were excluded. The data do not support effect of PncCRM on AOM in which only Ply-PCR suggests pneumococcal etiology.
Publication types
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Child, Preschool
-
Heptavalent Pneumococcal Conjugate Vaccine
-
Humans
-
Infant
-
Otitis Media / immunology
-
Otitis Media / microbiology
-
Otitis Media / prevention & control*
-
Pneumococcal Infections / immunology
-
Pneumococcal Infections / microbiology
-
Pneumococcal Infections / prevention & control*
-
Pneumococcal Vaccines / pharmacology*
-
Polymerase Chain Reaction
-
Streptococcus pneumoniae / genetics
-
Streptococcus pneumoniae / isolation & purification
-
Vaccines, Conjugate / pharmacology
Substances
-
Heptavalent Pneumococcal Conjugate Vaccine
-
Pneumococcal Vaccines
-
Vaccines, Conjugate